| APRIL, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
| ANIMAL HUSBANDRY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,430,061 | Method and apparatus for processing a large number of fish eggs | Hashimoto Electronic Industry Co., Ltd. | 30-Apr-13 | Japan |
| CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,431,346 | Screening for arthrogryposis multiplex in bovines | Agrigenomics, Inc. | 30-Apr-13 | United States |
| 8,426,123 | Method for conducting an assay for neutralizing antibodies | Biomonitor Limited | 23-Apr-13 | Ireland |
| 8,420,365 | 11.beta.hydroxysteroid dehydrogenase type 1 | Bristol-Myers Squibb Company | 16-Apr-13 | United States |
| 8,420,388 | Gene of porcine beta casein, a promoter of the same and the use thereof | Cho-A Pharm. Co., Ltd. | 16-Apr-13 | Korea |
| 8,426,165 | Process for producing fermentation product from carbon sources containing glycerol using Corynebacteria | CJ Cheiljedang Corporation | 23-Apr-13 | Korea |
| 8,426,181 | Method to improve the stability and broaden the pH range of family G/11 xylanases | Danisco US Inc. | 23-Apr-13 | United States |
| 8,426,182 | Alpha-amylase | DSM IP Assets B.V. | 23-Apr-13 | Netherlands |
| 8,409,796 | Method of regulating gene expression | Duke University | 2-Apr-13 | United States |
| 8,426,198 | In vitro differentiated cell and human embryonic stem cell population | Geron Corporation | 23-Apr-13 | United States |
| 8,409,809 | KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative disorders | Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt | 2-Apr-13 | Germany |
| 8,431,363 | Polynucleotides encoding therapeutic inhibitors of PAI-1 | Intrexon Corporation | 30-Apr-13 | United States |
| 8,409,856 | Compositions and their uses directed to gemin genes | Isis Pharmaceuticals, Inc. | 2-Apr-13 | United States |
| 8,420,357 | Recombinant microorganism capable of producing polylactate or polylactate copolymer from sucrose and method for producing polylactate or polylactate copolymer from sucrose using the same | LG Chem, Ltd. | 16-Apr-13 | Korea |
| 8,420,389 | Nipah virus vaccines | Merial Limited | 16-Apr-13 | United States |
| 8,431,373 | Recombinant microorganisms for increased production of organic acids | Michigan Biotechnology Institute | 30-Apr-13 | United States |
| 8,409,841 | Hydroxynitrile lyase | Mitsubishi Rayon Co., Ltd. | 2-Apr-13 | Japan |
| 8,415,160 | Transfection with micro explosion enacted by coated dry ice particles | National Yang Ming University | 9-Apr-13 | Taiwan |
| 8,431,393 | AIMP2-DX2 gene and its uses | Neomics Co., Ltd. | 30-Apr-13 | Korea |
| 8,420,314 | Method for detecting human papillomavirus mRNA | Norchip A/S | 16-Apr-13 | Norway |
| 8,431,382 | Chloramphenicol resistance selection in Bacillus licheniformis | Novozymes A/S | 30-Apr-13 | Denmark |
| 8,420,329 | Methods for diagnosing or treating prostate cancer | OncoTherapy Science, Inc. | 16-Apr-13 | Japan |
| 8,420,315 | Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene | Orion Genomics LLC | 16-Apr-13 | United States |
| 8,420,347 | Test mixture for detecting the presence or absence of methicillin resistant Staphylococcus aureus directly in a first generation test sample | Pilots Point LLC | 16-Apr-13 | United States |
| 8,426,133 | Methods for detecting gene dysregulation by intragenic differential expression | Quest Diagnostics Investments Incorporated | 23-Apr-13 | United States |
| 8,409,838 | Fucosylation-deficient cells | Regeneron Pharmaceuticals, Inc. | 2-Apr-13 | United States |
| 8,426,172 | Transformant capable of producing isopropanol | Research Institute of Innovation Technology for the Earth | 23-Apr-13 | Japan |
| 8,426,127 | Fluorescence-producing molecule | Riken | 23-Apr-13 | Japan |
| 8,420,310 | Method for detection of idiopathic interstitial pneumonia | Saga University | 16-Apr-13 | Japan |
| 8,426,128 | Methods and compositions for vitamin K epoxide reductase | The University of North Carolina at Chapel Hill | 23-Apr-13 | United States |
| 8,420,322 | Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotype (hp-1) and uses thereof | The Volcani Center--The State of Israel Ministry of Agriculture, Agricultural Research Organization | 16-Apr-13 | Israel |
| 8,426,130 | Methods of diagnosing alzheimer's disease and markers identified by set association | Translational Genomics Research Institute | 23-Apr-13 | United States |
| 8,420,391 | RNA sequence-specific mediators of RNA interference | University of Massachusetts | 16-Apr-13 | United States |
| 8,415,108 | Methods for diagnosing interstitial cystitis via nuclear localization of beta-catenin | University of Rochester | 9-Apr-13 | United States |
| 8,420,325 | Thermostable polymerases having altered fidelity and methods of identifying and using same | University of Washington Through Its Center for Commercialization | 16-Apr-13 | United States |
| 8,415,118 | Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof | Virginia Tech Intellectual Properties, Inc. | 9-Apr-13 | United States |
| 8,431,352 | Diagnosis of mood disorders by detecting latent infection with human herpesvirus-6 | Virus Ikagaku Kenkyusho Inc. | 30-Apr-13 | Japan |
| 8,415,146 | Vector and utilization of the same | Yokohama City University | 9-Apr-13 | Japan |
| DATA PROCESSING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,412,465 | Microarray-based gene copy number analyses | Board of Trustees of Michigan State University | 2-Apr-13 | United States |
| 8,412,460 | Methods and systems for characterizing a cellular constituent using response profiles | Microsoft Corporation | 2-Apr-13 | United States |
| 8,412,459 | Method for determining the allergic potential of a compound | Vlaamse Instelling Voor Technologisch Onderzoek | 2-Apr-13 | Belgium |
| 8,423,296 | Method for analyzing gene expression data | Yissum Research Development Company of the Hebrew University of Jerusalem | 16-Apr-13 | Israel |
| DRUG | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,431,119 | Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases | Aventis Pharma S.A. | 30-Apr-13 | France |
| 8,420,075 | Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases | Biovec, LLC | 16-Apr-13 | United States |
| 8,420,611 | Combined gene therapy for the treatment of macroscopic gliomas | Cedars-Sinai Medical Center | 16-Apr-13 | United States |
| 8,420,619 | Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein | Ceregene, Inc. | 16-Apr-13 | United States |
| 8,431,547 | Synthetic genes and genetic constructs | Commonwealth Scientific and Industrial Research Organisation | 30-Apr-13 | Australia |
| 8,415,320 | Delivery of dsRNA to arthropods | Commonwealth Scientific and Industrial Research Organisation | 9-Apr-13 | Australia |
| 8,431,543 | Chitosan based polymer conjugate and a method for producing the same | Engene, Inc | 30-Apr-13 | Canada |
| 8,420,698 | Histone deacetylase inhibitors | Errant Gene Therapeutics, LLC | 16-Apr-13 | United States |
| 8,431,544 | Compositions for inhibiting gene expression and uses thereof | Idera Pharmaceuticals, Inc. | 30-Apr-13 | United States |
| 8,420,104 | Lentiviral gene transfer vectors and their medicinal applications | Institut Pasteur | 16-Apr-13 | France |
| 8,420,601 | Biocompatible materials containing stable complexes of TSG-6 and hyaluronan and method of using same | New York University | 16-Apr-13 | United States |
| 8,409,566 | Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis | Northwest Biotherapeutics, Inc. | 2-Apr-13 | United States |
| 8,425,895 | Recombinant human interferon-like proteins | Novagen Holding Corporation | 23-Apr-13 | United States |
| 8,410,069 | Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer | Quark Pharmaceuticals, Inc. | 2-Apr-13 | United States |
| 8,425,896 | Treatment of tumors with recombinant interferon alpha | Sichuan Biotechnology Research Center | 23-Apr-13 | China P Rep |
| 8,426,380 | Inhibition of viral gene expression using small interfering RNA | Somagenics, Inc. | 23-Apr-13 | United States |
| 8,420,101 | Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli | South Dakota State University | 16-Apr-13 | United States |
| 8,425,876 | Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof | The Brigham and Women's Hospital, Inc. | 23-Apr-13 | United States |
| 8,414,891 | Method for treating pulmonary hypertension | The Johns Hopkins University | 9-Apr-13 | United States |
| 8,431,542 | Micrornas that regulate muscle cell proliferation and differentiation | The University of North Carolina at Chapel Hill | 30-Apr-13 | United States |
| 8,426,376 | Angiogenesis inhibitor | Tohoku Technoarch Co., Ltd. | 23-Apr-13 | Japan |
| 8,410,070 | Compositions and methods for treating cancer, inhibiting proliferation, and inducing cell death | University of Louisville Research Foundation, Inc. | 2-Apr-13 | United States |
| 8,410,054 | Methods for treating pain by inhibition of the SCN9A channel | Xenon Pharmaceuticals Inc. | 2-Apr-13 | Canada |
| MULTICELLULAR LIVING ORGANISMS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,426,677 | Method of controlling plant growth and architecture by controlling expression of gibberellin 2-oxidase | Academia Sinica | 23-Apr-13 | Taiwan |
| 8,426,675 | Methods for producing microRNAs | Cold Spring Harbor Laboratory | 23-Apr-13 | United States |
| 8,420,890 | Use of NAP gene to manipulate leaf senescence in plants | Cornell Research Foundation, Inc. | 16-Apr-13 | United States |
| 8,415,526 | Down-regulation of gene expression using artificial microRNAs | E. I. du Pont de Nemours and Company | 9-Apr-13 | United States |
| 8,420,886 | Transgenic mouse comprising a disrupted Fibulin-4 gene as a model for cardiovascular disease | Erasmus University Medical Center Rotterdam | 16-Apr-13 | Netherlands |
| 8,410,334 | Invertebrate microRNAs | Monsanto Technology LLC | 2-Apr-13 | United States |
| 8,415,527 | DNA constructs and methods to enhance the production of commercially viable transgenic plants | Monsanto Technology LLC | 9-Apr-13 | United States |
| 8,410,341 | Nucleic acid encoding N-methylputrescine oxidase and uses thereof | National Research Council of Canada | 2-Apr-13 | Canada |
| 8,410,335 | Method for producing rose with altered petal colors | Suntory Holdings Limited | 2-Apr-13 | Japan |
| 8,431,773 | Promotion of somatic embryogenesis in plants by wuschel gene expression | The Rockefeller University | 30-Apr-13 | United States |
| 8,431,768 | Targeted and regional cellular ablation in zebrafish | Washington University | 30-Apr-13 | United States |
| NATURAL RESINS OR DERIVATIVES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,420,785 | Soluble human ST-2 antibodies and assays | Critical Care Diagnostics, Inc. | 16-Apr-13 | United States |
| ORGANIC COMPOUNDS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,426,571 | Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer | Agensys, Inc. | 23-Apr-13 | United States |
| 8,410,261 | Compositions and methods for inhibiting expression of a gene from the JC virus | Alnylam Pharmaceuticals, Inc. | 2-Apr-13 | United States |
| 8,426,580 | Microbacterial peptide deformylase | Council of Scientific and Industrial Research | 23-Apr-13 | United States |
| 8,426,579 | SiRNA targeting myeloid differentiation primary response gene (88) (MYD88) | Dharmacon, Inc. | 23-Apr-13 | United States |
| 8,410,257 | Nucleotide sequences encoding RAMOSA3 and Sister of RAMOSA3 and methods of use for same | E I du Pont de Nemours and Company | 2-Apr-13 | United States |
| 8,415,463 | Potexvirus-derived replicon | Icon Genetics GmbH | 9-Apr-13 | Germany |
| 8,426,581 | RNA interference mediated inhibition of the FC.epsilon.R1.alpha. gene | Merck Sharp & Dohme Corp. | 23-Apr-13 | United States |
| 8,431,692 | Compositions and methods for treatment of ear disorders | Quark Pharmaceuticals, Inc. | 30-Apr-13 | United States |
| SURGERY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,433,423 | Methods for multi-vessel renal neuromodulation | Ardian, Inc. | 30-Apr-13 | United States |
| 8,409,166 | Method for pressure mediated selective delivery of therapeutic substances and cannula | The United States of America as represented by the Secretary of the Department of Health and Human Services | 2-Apr-13 | United States |
Login
To traslate this page, click a flag!
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
